Cumberland Pharmaceuticals Inc. (CPIX)
NASDAQ · Healthcare
Cumberland Pharmaceuticals Inc. EBITDA 2009–2025
Cumberland Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cumberland Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2026 was -1.9 M, a 179.75% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2026 was -524046, a 262.03% decrease year-over-year.
- Cumberland Pharmaceuticals Inc. annual ebitda for 2025 was 1.4 M, a 188.45% decrease from 2024.
- Cumberland Pharmaceuticals Inc. annual ebitda for 2024 was -1.5 M, a 66.88% decrease from 2023.
- Cumberland Pharmaceuticals Inc. annual ebitda for 2023 was -4.6 M, a 1125.72% increase from 2022.
- Cumberland Pharmaceuticals Inc. annual ebitda for 2022 was -376816.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cumberland Pharmaceuticals Inc. EBITDA — FAQ
Cumberland Pharmaceuticals Inc. (CPIX) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPIX's ebitda history?
The chart and table above show Cumberland Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.